Protective role of arginase in a mouse model of colitis

Journal of Immunology

Volumn 173, Issue 3, 2004, Pages 2109-2117

  Gobert, Alain P ^a,b,e   Cheng, Yulan ^a,b   Akhtar, Mahmood ^a,b   Mersey, Benjamin D ^a,b   Blumberg, Darren R ^a   Cross, Raymond K ^a   Chaturvedi, Rupesh ^a,b   Drachenberg, Cinthia B ^a   Boucher, Jean Luc ^c   Hacker, Amy ^d   Casero Jr , Robert A ^d   Wilson, Keith T ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

(2 BORONOETHYL)CYSTEINE; ARGINASE; ARGINASE I; ARGINASE II; ARGINASE INHIBITOR; CYSTEINE DERIVATIVE; EFLORNITHINE; ENZYME INHIBITOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; ORNITHINE; ORNITHINE DECARBOXYLASE; POLYAMINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER; CITROBACTER RODENTIUM; COLITIS; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME INDUCTION; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; GENE DELETION; GENE EXPRESSION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL;

EID: 3242761284     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.3.2109     Document Type: Article

References (47)

1. Morteau, O., S. G. Morham, R. Sellon, L. A. Dieleman, R, Langenbach, O. Smithies, and R. B. Sartor. 2000. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105:469.
2. Fuss, I. J., M. Boirivant, B. Lacy, and W. Strober. 2002. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J. Immunol. 168:900.
3. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established, experimental colitis in mice. J. Exp. Med. 182:1281.
4. Kankuri, E., K. Vaali, R. G. Knowles, M. Lahde, R. Korpela, H. Vapaatalo, and E. Moilanen. 2001. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor. N-[3-(aminomethyl)benzyl] acetamidine. J. Pharmacol. Exp. Ther. 298:1128.
5. Dikopoulos, N., A. K. Nussler, S. Liptay, M. Bachem, M. Reinshagen, M. Stiegler, R. M. Schmid, G. Adler, and H. Weidenbach. 2001. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur. J. Clin. Invest. 31:234.
6. McCafferty, D. M., J. S. Mudgett, M. G. Swain, and P. Kubes. 1997. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112:1022.
7. McCafferty, D. M., M. Miampamba, E. Sihota, K. A. Sharkey, and P. Kubes. 1999. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45:864.
8. Hokari, R., S. Kato, K. Matsuzaki, M. Kuroki, A. Iwai, A. Kawaguchi, S. Nagao, T. Miyahara, K. Itoh, E. Sekizuka, et al. 2001. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radical Biol. Med 31:153.
9. Krieglstein, C. F., W. H. Cerwinka, F. S. Laroux, J. W. Salter, J. M. Russell, G. Schuermann, M. B. Grisham, C. R. Ross, and D. N. Granger. 2001. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of Superoxide and nitric oxide. J. Exp. Med. 194:1207.
10. Gobert, A. P., S. Daulouede, M. Lepoivre, J. L. Boucher, B. Bouteille, A. Buguet, R. Cespuglio, B. Veyret, and P. Vincendeau. 2000. L-arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis. Infect. Immun. 68:4653.
11. Gobert, A. P., Y. Cheng, J. Y. Wang, J. L. Boucher, R. K. Iyer, S. D. Cederbaum, R. A. Casero, Jr., J. C. Newton, and K. T. Wilson. 2002. Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol. 168:4692.
12. Huang, J., F. J. DeGraves, S. D. Lenz, D. Gao, P. Feng, D. Li, T. Schlapp, and B. Kaltenboeck. 2002. The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. Proc. Natl. Acad. Sci. USA 99:3914.
13. Ignarro, L. J., G. M. Buga, L. H. Wei, P. M. Bauer, G. Wu. and P. del Soldato. 2001. Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc. Natl. Acad. Sci. USA 98:4202.
14. G-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am. J. Physiol. 275:RI256.
15. Morris, S. M., Jr., D. Kepka-Lenhart, and L. C. Chen. 1998. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am. J. Physiol. 275:740.
16. Iyer, R. K., J. M. Bando, C. P. Jenkinson, J. G. Vockley, P. S. Kim, R. M. Kern, S. D. Cederbaum, and W. W. Grody. 1998. Cloning and characterization of the mouse and rat type II arginase genes. Mol. Genet. Metab. 63:168.
17. Li, H., C. J. Meininger, J. R. Hawker, Jr., T. E. Haynes, D. Kepka-Lenhart, S. K. Mistry, S. M. Morris, Jr., and G. Wu. 2001. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am. J. Physiol. 280:E75.
18. Gobert, A. P., D. J. McGee, M. Akhtar, G. L. Mendz, J. C. Newton, Y. Cheng, H. L. Mobley, and K. T. Wilson. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl Acad. Sci. USA 98:13844.
19. Higgins, L. M., G. Franket, I. Connerton, N. S. Concalves, G. Dougan, and T. T. MacDonald. 1999. Role of bacterial intimin in colonic hyperplasia and inflammation. Science 285:588.
20. Higgins, L. M., G. Frankel, G. Douce, G. Dougan, and T. T. MacDonald. 1999. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 67:3031.
21. Kim, N. N., J. D. Cox, R. F. Baggio, F. A. Emig, S. K. Mistry, S. L. Harper, D. W. Speicher, S. M. Morris, Jr., D. E. Ash, A. Traish, and D. W. Christianson. 2001. Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum. Biochemistry 40:2678.
22. Wilson, K. T., S. Fu, K. S. Ramanujam, and S. J. Meltzer. 1998. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 58:2929.
23. Fu, S., K. S. Ramanujam, A. Wong, G. T. Fantry, C. B. Drachenberg, S. P. James, S. J. Meltzer, and K. T. Wilson. 1999. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116:1319.
24. 1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res. 49:3829.
25. Wu, G., and S. M. Morris, Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1.
26. Shi, O., S. M. Morris, Jr., H. Zoghbi, C. W. Porter, and W. E. O'Brien. 2001. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol. Cell. Biol. 21:811.
27. 12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells. J. Biol. Chem. 264:11744.
28. Poulin, R., L. Lu, B. Ackermann, P. Bey, and A. E. Pegg. 1992. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by α-difluoromethylornithine: characterization of sequences at the inhibitor and coenzyme binding sites. J. Biol. Chem. 267:150.
29. Munder, M., K. Eichmann, J. M. Moran, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regutated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163:3771.
30. Louis, C. A., J. S. Reichner, W. L. Henry, Jr., B. Mastrofrancesco, T. Gotoh, M. Mori, and J. E. Albina. 1998. Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am. J. Physiol. 274:R775.
31. Cheng, Y., H. Xu, J. S. Forman, P. C. Panchal, D. R, Blumberg, R. Chaturvedi, F. I. Bussiere, C. B. Drachenberg, A. P. Gobert, and K. T. Wilson. 2003. Inhibition of colitis by the arginase-ODC pathway. Gastroenterology 124:A473.
32. Waddington, S. N., K. Mosley, H. T. Cook, F. W. Tam, and V. Cattell. 1998. Arginase AI is up-regulated in acute immune complex-induced inflammation. Biochem. Biophys. Res. Commun. 247:84.
33. Cross, R. K., and K. T. Wilson. 2003. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel Dis. 9:179.
34. Bauer, P. M., G. M. Buga, J. M. Fukuto, A. E. Pegg, and L. J. Ignarro. 2001. Nitric oxide inhibits ornithine decarboxylase via S-nitrosylation of cysteine 360 in the active site of the enzyme. J. Biol. Chem. 276:34458.
35. Zhang, M., T. Caragine, H. Wang, P. S. Cohen, G. Botchkina, K. Soda, M. Bianchi, P. Ulrich, A. Cerami, B. Sherry, and K. J. Tracey. 1997. Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counter-regulatory mechanism that restrains the immune response. J. Exp. Med. 185:1759.
36. 2+-RhoA signaling pathway required for polyamine-dependent intestinal epithelial cell migration. Am. J. Physiol. 280:C993.
37. Li, L., J. N. Rao, X. Guo, L. Liu, R. Santora, B. L. Bass, and J. Y. Wang. 2001. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am. J. Physiol. 281:C941.
38. Schipper, R. G., L. C. Penning, and A. A. Verhofstad. 2000. Involvement of polyamines in apoptosis: facts and controversies: effectors or protectors? Semin. Cancer Biol. 10:55.
39. Wang, J. Y., and L. R. Johnson. 1991. Polyamines and ornithine decarboxylase during repair of duodenal mucosa after stress in rats. Gastroenterology 100:333.
40. Yamada, T., K. Fujimoto, P. Tso, T. Fujimoto, T. S. Gaginella, and M. B. Grisham. 1992. Misoprostol accelerates colonic mucosal repair in acetic acid-induced colitis. J. Pharmacol. Exp. Ther. 260:313.
41. Shearer, J. D., J. R. Richards, C. D. Mills, and M. D. Caldwell. 1997. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272:E181.
42. Vallance, B. A., W. Deng, M. De Grado, C. Chan, K. Jacobson, and B. B. Finlay. 2002. Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect. Immun. 70:6424.
43. Simmons, C. P., N. S. Goncalves, M. Ghaem-Maghami, M. Bajaj-Elliott, S. Clare, B. Neves, G. Frankel, G. Dougan, and T. T. MacDonald. 2002. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-γ. J. Immunol. 168:1804.
44. Pillai, R. B., V. Tolia, R. Rabah, P. M. Simpson, R. Vijesurier, and C. H. Lin. 1999. Increased colonic ornithine decarboxylase activity in inflammatory bowel disease in children. Dig. Dis. Sci. 44:1565.
45. Ricci, G., G. Stabellini, G. Bersani, G. Marangoni, P. Fabbri, G. Gentili, and V. Alvisi. 1999. Ornithine decarboxylase in colonic mucosa from patients with moderate or severe Crohn's disease and ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 11:903.
46. Obayashi, M., I. Matsui-Yuasa, T. Matsumoto, A. Kitano, K. Kobayashi, and S. Otani. 1992. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis. Am. J. Gastroenterol. 87:736.
47. Wei, L. H., S. M. Morris, Jr., S. D. Cederbaum, M. Mori, and L. J. Ignarro. 2000. Induction of arginase II in human caco-2 tumor cells by cyclic AMP. Arch. Biochem. Biophys. 374:255.